Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
Study Shows How Extra PMP22 Gene in Patients with CMT1A May Cause Cellular Toxicity
qimono / Pixabay

Study Shows How Extra PMP22 Gene in Patients with CMT1A May Cause Cellular Toxicity

According to Charcot-Marie-Tooth News, patients with Charcot-Marie-Tooth disease type 1A (CMT1A) have an extra PMP22 gene. However, new research shows that this excess gene causes a toxic accumulation of protein within cells.…

Continue Reading Study Shows How Extra PMP22 Gene in Patients with CMT1A May Cause Cellular Toxicity
BioMarin Holds Clinical Study to Determine Antibodies that Might Impact Gene Therapy
GCMpublicitat / Pixabay

BioMarin Holds Clinical Study to Determine Antibodies that Might Impact Gene Therapy

Last month, biotechnology company BioMarin sought approval for an investigational gene therapy (valoctocogene roxaparvovec) for patients with hemophilia A. However, their approval was denied. Instead, the company was told that…

Continue Reading BioMarin Holds Clinical Study to Determine Antibodies that Might Impact Gene Therapy
Cornell and reVision Therapeutics Will Work Together to Develop Stargardt Disease Treatment
source: pixabay.com

Cornell and reVision Therapeutics Will Work Together to Develop Stargardt Disease Treatment

Cornell University and reVision Therapeutics have come together through a licensing agreement to develop a treatment for Stargardt disease, according to BioSpace. They will be working on and commercializing Cornell's…

Continue Reading Cornell and reVision Therapeutics Will Work Together to Develop Stargardt Disease Treatment
COVID-19 and Heart Damage: What You Need to Know
source: pixabay.com

COVID-19 and Heart Damage: What You Need to Know

According to a story from Buzzfeed News, the coronavirus/COVID-19 pandemic continues to present new surprises and challenges to the medicine and science communities. In a recent interview, Wayne Sebastianelli, who…

Continue Reading COVID-19 and Heart Damage: What You Need to Know
Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial
source: pixabay.com

Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial

According to a story from Pharmaceutical Business Review, the pharmaceutical company Bayer has recently announced encouraging findings from its phase 4 clinical study. This trial was testing the drug riociguat…

Continue Reading Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial
New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study
source: pixabay.com

New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Ionis Pharmaceuticals has just released their findings from a study investigating the effect of IONIS-PKK-LRx and IONIS-PKKRx in hereditary angioedema (HAE) patients with different forms of the disease. These therapies work to reduce…

Continue Reading New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Study Finds New Therapy to be Efficacious for Rheumatoid Arthritis Patients Unresponsive to Methotrexate

A new study published in the journal Rheumatology and Therapy examined the effect of baricitinib on Rheumatoid Arthritis (RA) patients who have had an inadequate to their methotrexate therapy. Methotrexate and Baricitinib…

Continue Reading Study Finds New Therapy to be Efficacious for Rheumatoid Arthritis Patients Unresponsive to Methotrexate
Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
source: pixabay.com

Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers

Researchers in Canada have just released positive results from their heterozygous familial hypercholesterolemia (HeFH) clinical trial. This investigation was examining the effect of Repatha on teenagers with the condition. The trial…

Continue Reading Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
source: pixabay.com

ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder

Health Canada has recently granted market authorization to Hoffman La-Roche Limited for their neuromyelitis optica spectrum disorder treatment, ENSPRYNG. Canada is the first country to offer this medication, and hopefully…

Continue Reading ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
More Research Needed to Help Postmenopausal Females at Risk for Nonalcoholic Fatty Liver Disease
source: pixabay.com

More Research Needed to Help Postmenopausal Females at Risk for Nonalcoholic Fatty Liver Disease

by Natalie Homan from In The Cloud Copy A review article published in Endocrinology in August of this year highlights the fact that a female's risk of developing nonalcoholic fatty…

Continue Reading More Research Needed to Help Postmenopausal Females at Risk for Nonalcoholic Fatty Liver Disease